In addition, upregulation of Nav1.8 mRNA and protein expression with pharmacologically demonstrable functional effects in both cardiac tissue and cardiomyocytes, accompanied both cardiac failure [44] and hypertrophy [19], suggesting direct cardiomyocyte roles in diseased and/or remodelled hearts. The gene discussed is SCN10A; the disease is heart failure.